| MBOT Stock | | | USD 0.99 0.01 1.02% |
CTO
MSc MBA is CTO Israel of Microbot Medical
| Age | 64 |
| Address | 288 Grove Street, Braintree, MA, United States, 02184 |
| Phone | 781 875 3605 |
| Web | https://microbotmedical.com |
Microbot Medical Management Efficiency
The company has return on total asset
(ROA) of
(0.6488) % which means that it has lost $0.6488 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity
(ROE) of
(1.3446) %, meaning that it created substantial loss on money invested by shareholders. Microbot Medical's management efficiency ratios could be used to measure how well Microbot Medical manages its routine affairs as well as how well it operates its assets and liabilities.
Return On Tangible Assets is likely to gain to -1.23 in 2024.
Return On Capital Employed is likely to gain to -2.06 in 2024.
Total Current Liabilities is likely to gain to about 4.8
M in 2024, whereas
Liabilities And Stockholders Equity is likely to drop slightly above 7.9
M in 2024.
Microbot Medical currently holds 231
K in liabilities with Debt to Equity
(D/E) ratio of 0.07, which may suggest the company is not taking enough advantage from borrowing. Microbot Medical has a current ratio of 5.49, suggesting that it is
liquid enough and is able to pay its financial obligations when due. Note, when we think about Microbot Medical's use of debt, we should always consider it together with its cash and equity.
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts. Microbot Medical operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 20 people. Microbot Medical (MBOT) is traded on NASDAQ Exchange in USA. It is located in 288 Grove Street, Braintree, MA, United States, 02184 and employs 21 people. Microbot Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification.
Management Performance
Microbot Medical Leadership Team
Elected by the shareholders, the Microbot Medical's board of directors comprises two types of representatives: Microbot Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Microbot. The board's role is to monitor Microbot Medical's management team and ensure that shareholders' interests are well served. Microbot Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Microbot Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Microbot Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Microbot Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Microbot Stock Analysis
When running Microbot Medical's price analysis, check to
measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to
predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.